Publications
Specialty
Search
Cancer Care Business Exchange, Journal of Clinical Pathways, Clinical Pathways
05/20/2024
In part two of this two-part Breaking Down Health Care conversation, John Hennessy, MBA, and Michael Kolodziej, MD, dig into the other main stakeholders in health care costs: pharmaceutical manufacturers and providers. They discuss how these entities contribute to the current high costs of care in the US and how they can help control those costs for patients.
Gastroenterology
05/20/2024
Tight glycemic control among patients with Type 2 diabetes is associated with reduced risks of colorectal cancer and colorectal adenoma, researchers said at Digestive Disease Week.
Advances in Inflammatory Bowel Disease Network, Gastroenterology
05/20/2024
Further research is warranted to fully understand the safety profile of tofacitinib during pregnancy, but to date outcomes have been positive.
Gastroenterology
05/20/2024
Patients with concurrent celiac disease and eosinophilic esophagitis (EOE) had significantly lower odds of dysphagia and food bolus impaction compared to those with EOE alone.
Advances in Inflammatory Bowel Disease Network, Gastroenterology
05/20/2024
COMMAND study indicates duration of exposure to risankizumab rather than the dose may be a primary factor in response and remission among patients with ulcerative colitis.
EP Lab Digest
05/19/2024
New clinical trials demonstrate the safety and efficacy of improvements in cardiac implantable electronic devices and complementary pharmacotherapy
EP Lab Digest
05/19/2024
This physician-initiated prospective, randomized clinical trial sponsored by The National Heart, Lung, and Blood Institute found that early cardiac resynchronization therapy (CRT) may slow the progression of heart failure in patients with mild to moderately reduced left ventricular ejection fraction (LVEF) and left bundle branch block (LBBB).
EP Lab Digest
05/18/2024
Additional data from APPRAISE ATP trial reinforce modular therapy approach with EMBLEM™ Subcutaneous Implantable Defibrillator and EMPOWER™ Leadless Pacemaker
EP Lab Digest
05/18/2024
The PREDIMAR study, led by researchers at the University of Navarra, University Hospital HM Monteprincipe, Virgen de las Nieves Hospital and General Hospital of Alicante in Spain, is one of the few trials to evaluate the effects of a specific diet on patients with AF after ablation to reduce the risk of recurrence.
EP Lab Digest
05/18/2024
Safer and faster procedures: New data from three late-breaking clinical trials continues to support pulsed field ablation as a superior treatment option for atrial fibrillation
Oncology
05/18/2024
At Great Debates and Updates in Gastrointestinal Malignancies in New York, New York, Ryan Moy, MD, PhD, discussed first-line use of PD-1 inhibitors for the treatment of patients with gastroesophageal cancers.
Oncology
05/18/2024
At Great Debates and Updates in Gastrointestinal Malignancies in New York, New York, Samuel Cytryn, MD, discussed first-line use of claudin-18.2 inhibitors for patients with gastroesophageal cancers.
EP Lab Digest
05/17/2024
HRS late breaking data: SPHERE Per-AF trial demonstrates novel all-in-one system delivers exceptional results, plus increased efficiency and improved quality of life
Psych Congress Network
05/17/2024
A literature review presented via poster at the 2024 American Psychiatric Association Annual Meeting in New York City suggests that video games may not be all-harm in effect for youth with ADHD.
Podiatry Today, Wound Care
05/17/2024
Dr. Vlahovic shares key points from her Rapid Fire session at SAWC.
EP Lab Digest
05/17/2024
The Heart Rhythm Society leads an international group of experts in outlining strategies for the evaluation and treatment of arrhythmias, facilitating athletes’ safe participation in sports
EP Lab Digest
05/17/2024
Three studies demonstrate how Philips MCOT wearable ambulatory monitoring ECG and proprietary AI models applied to ECG digital biomarkers can help to improve diagnosis, reduce readmissions, and lower costs
EP Lab Digest
05/17/2024
Global LEADR clinical trial meets safety and effectiveness objectives; results presented at Heart Rhythm 2024 and simultaneously published in Heart Rhythm
Psych Congress Network
05/17/2024
Lenard A.
Pharmacy Learning Network
05/17/2024
“Prescription medications, when misused, can pose a grave threat to public health,” said Acting Special Agent in Charge Steven L. Hofer of the DEA. “That’s why meticulous recordkeeping by pharmacies is an essential line of defense against the opioid crisis. Every dose, every pill meticulously accounted for protects communities and saves lives.”